IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Essex Woodlands Management, Inc.

Q4 2024 Holdings

Filed 2025-02-13 | 7 holdings | $433.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Mimedx Group, Inc.(MDXG)COM602496101$271.2M28,195,24962.6%
Bioventus(BVS)COM CL A09075A108$136.7M13,021,32431.6%
Tela BIO, Inc.(TELA)COM872381108$12.4M4,110,7092.9%
Eyepoint Pharmaceuticals Inc(EYPT)COM NEW30233G209$8.7M1,169,8572.0%
Medicinova Inc(MNOV)COM NEW58468P206$2.3M1,105,9410.5%
Revance Therapeutics Inc(RVNCEUR)COM761330109$1.4M457,0850.3%
Venus Concept, Inc.COM92332W204$413.9K1,089,1900.1%